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Abstract Adenosine is a biologically active molecule that
is formed at sites of metabolic stress associated with trauma
and inflammation, and its systemic level reaches high
concentrations in sepsis. We have recently shown that
inactivation of A2A adenosine receptors decreases bacterial
burden as well as IL-10, IL-6, and MIP-2 production in
mice that were made septic by cecal ligation and puncture
(CLP). Macrophages are important in both elimination of
pathogens and cytokine production in sepsis. Therefore, in
the present study, we questioned whether macrophages are
responsible for the decreased bacterial load and cytokine
production in A2A receptor-inactivated septic mice. We
showed that A2A KO and WT peritoneal macrophages
obtained from septic animals were equally effective in
phagocytosing opsonized E. coli. IL-10 production induced
by opsonized E. coli was decreased in macrophages
obtained from septic A2A KO mice as compared to WT
counterparts. In contrast, the release of IL-6 and MIP-2
induced by opsonized E. coli was higher in septic A2A KO
macrophages than WT macrophages. These results suggest
that peritoneal macrophages are not responsible for the
decreased bacterial load and diminished MIP-2 and IL-6
production that are observed in septic A2A KO mice. In
contrast, peritoneal macrophages may contribute to the
suppressive effect of A2A receptor inactivation on IL-10
production during sepsis.
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Abbreviations
IL Interleukin
MIP-2 Macrophage-inflammatory protein-2
EHNA Erythro-9-(2-hydroxy-3-nonyl)adenine, aden-
osine deaminase inhibitor
ZM241385 4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a)
[1,3,5]triazin-5-ylamino]ethyl) phenol, selec-
tive A2A receptor antagonist
Introduction
Severe sepsis is an extremely costly medical problem in the
United States and develops in >750,000 people annually.
Although the treatment of primary infections per se is well-
established, ~200,000 deaths/year occur as a result of
residual sepsis and multiple organ dysfunction [1, 2].
Current theory suggests that the sepsis syndrome is
associated with an early overwhelming innate immune
response, characterized by unabated activation and release
of pro-inflammatory mediators. Subsequently, the exagger-
ated systemic inflammatory response is counterbalanced by
sustained expression of potent anti-inflammatory media-
tors, which often results in the desensitization of effector
cells (such as phagocytes) and development of a hypo-
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Bethesda, MD 20892-8115, USAimmune or “immunoparalytic” state. In fact, the inability
to kill invading pathogens effectively at later stages during
sepsis is due to immunosupression, and it is also a major
cause of late organ dysfunction syndrome [3, 4]. Potential
mechanisms of immune suppres s i o na f t e ras e p t i ci n s u l t
include decreased antigen presentation, diminished phago-
cytosis of pathogens, as well as dysregulation in cytokine
production [5–9].
Adenosine, an endogenous purine nucleoside, is a
biologically active extracellular signaling molecule that is
formed at sites of metabolic stress associated with hypoxia,
ischemia, trauma, or inflammation. Systemic adenosine
levels are highly elevated in septic patients [10–12].
Adenosine acts by engaging A1,A 2A,A 2B,a n dA 3
adenosine receptors [13], through which it can exert
immunosuppressive effects [14–21]. Besides the immuno-
modulatory effect of A3 [22, 23] and A2B receptors [24], the
most potent immunosuppressive effects of adenosine are
attributed to occupancy of A2A receptors on immune cells.
Stimulation of A2A receptors induces many phenotypic
changes in immune cells that are characteristic of the late
“immunoparalytic” phase of sepsis [25–30]. We demon-
strated previously, by using genetic and pharmacological
inactivation of the A2A receptor in the clinically relevant
cecal ligation and puncture (CLP) model of sepsis [31] that
stimulation of A2A receptors contributed to the lethal effect
of sepsis and led to increased bacterial burden [32].
Furthermore, stimulation of A2A receptors increased levels
of the immunoregulatory cytokines IL-10, IL-6, and MIP-2.
Because macrophages are important in mediating cytokine
production and anti-bacterial defense in septic mice, we
questioned whether the increased bacterial burden and
cytokine production caused by the activation of A2A
receptors in septic animals are mediated by macrophages.
Materials and methods
Experimental animals and cell cultures
A2A receptor KO mice and their WT littermates [32, 33]
on the CD-1 background were bred in a specific pathogen-
free facility, using founder heterozygous male and female
mice. CD-1 male mice were purchased from Charles River
Laboratories. All mice were maintained in accordance
with the recommendations of the “G u i d ef o rt h eC a r ea n d
Use of Laboratory Animals,” and the experiments were
approved by the New Jersey Medical School Animal Care
Committee. WT and KO littermates of heterozygous
parents were used exclusively in all studies. At weaning,
a 0.5-cm tail sample was removed for the purpose of DNA
collection for genotyping. Genotyping was performed by
using RT-PCR as described previously [32–34]. CLP-
elicited mouse peritoneal macrophages were cultured in
Dulbeccos’s modified Eagle’s Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 50 U/ml
penicillin, 50 μg/ml streptomycin, and 1.5 mg/ml sodium
bicarbonate in a humified atmosphere of 95% air and 5%
CO2.
Cecal ligation and puncture
Polymicrobial sepsis was induced by subjecting mice to
CLP, as we have described previously [32]. Six- to eight-
week-old male A2AR KO or WT mice were anesthetized
with pentobarbital (50 mg/kg), given intraperitoneally (i.p.).
Under aseptic conditions, a 2-cm midline laparotomy was
performed to allow exposure of the cecum with adjoining
intestine. Approximately two-thirds of the cecum was
tightly ligated with a 3.0 silk suture, and the ligated part
of the cecum was perforated twice (through and through)
with a 20-gauge needle (BD Biosciences). The cecum was
then gently squeezed to extrude a small amount of feces
from the perforation sites. The cecum was then returned to
the peritoneal cavity, and the laparotomy was closed in two
layers with 4.0 silk sutures. The mice were resuscitated
with 1 ml of physiological saline injected subcutaneously
(s.c.) and returned to their cages with free access to food
and water.
Harvesting of peritoneal macrophages
Sixteen hours after the operation, mice were reanesthetized
with pentobarbital (50 mg/kg i.p.), and peritoneal macro-
phages were harvested in 4 ml of sterile physiological
saline. Peritoneal cells were seeded into multiwell tissue
culture plates. After 4 h of incubation, nonadherent cells
were removed by washing with serum-free DMEM,
following which phagocytosis assay was performed.
Opsonization of E. coli and phagocytosis assay
Fluorescein isothiocyanate (FITC)-labeled E. coli (Molec-
ular Probes) were opsonized by incubation with an equal
volume of opsonizing reagent (Molecular Probes) for 1 h at
37°C. The bacteria were then washed twice in phosphate-
buffered saline and added to macrophages at a macrophage-
to-bacteria ratio of 1:50 for 2.5, 5, or 16 h. At the end of the
incubation period, the medium was removed and frozen
until use in ELISA experiments (see below). Thereafter,
100 μlo f2 5 0μg/ml Trypan Blue suspension was added to
all wells for 1 min. The Trypan Blue solution was then
removed by aspiration, and the experimental and control
wells (without peritoneal macrophages) were read with a
fluorescence plate reader at 480 nm for excitation and
520 nm for emission.
448 Purinergic Signalling (2007) 3:447–452Determination of IL-10, IL-6, and MIP-2 cytokine levels
IL-10, IL-6, and MIP-2 cytokine levels were determined
from cell supernatants taken at the indicated points
following treatment of macrophages with opsonized bacte-
ria. Cytokine concentrations were measured using DuoSet
ELISA kits (R&D Systems) according to the manufac-
turer’s instructions.
Statistical analysis
Values in the figures are expressed as mean ± SEM of n
observations. Statistical analysis of the data was performed
by one-way analysis of variance followed by Dunnett’s test,
as appropriate.
Results
Effect of A2A adenosine receptor inactivation
on macrophage phagocytosis of opsonized E. coli
Macrophages play an essential role in the innate immune
response against bacterial invasion, and they also eliminate
bacteria from the peritoneum and bloodstream during sepsis.
Since the inactivation of A2A receptors enhances bacterial
clearance, we first examined whether the absence of A2A
receptors has any impact on the phagocytic activity of
peritoneal macrophages. As illustrated in Fig. 1, no signif-
icant differences in macrophage phagocytotic activity were
detected between A2A WT (n=5) or A2A KO (n=8) cells.
Effect of A2A adenosine receptor inactivation
on macrophage cytokine release
IL-10 is a potent anti-inflammatory and immunosuppressive
cytokine that has been shown to be elevated in patients with
sepsis. We have previously shown that its level was markedly
lower in A2A KO mice than its WT littermates under septic
conditions. Therefore, we measured the IL-10 level after
stimulation with opsonized E. coli in CLP-elicited peritoneal
macrophages. We observed that opsonized E. coli enhanced
IL-10 levels (n=30 in case of A2A WT), the induction of
which was inhibited by genetic inactivation of A2A receptors
(n=48 in case of A2A KO) (Fig. 2).
Our previous work has shown that the level of IL-6 was
markedly lower in the bloodstream of A2A KO receptor
mice compared with their WT counterparts in CLP-induced
polymicrobial sepsis [32]. To assess the effect of A2A
receptor inactivation on IL-6 release by macrophages, CLP-
elicited peritoneal macrophages were stimulated with
opsonized E. coli. We found that the IL-6 level was
markedly higher in A2A KO macrophages stimulated with
opsonized E. coli (n=48) than in WT (n=30) macrophages
at 2.5 h, and this difference was even more robust at 5 and
16 h (Fig. 3).
We previously observed that MIP-2 production was
decreased both in the bloodstream and in the peritoneum of
A2A KO vs. WT mice under septic conditions [32].
Consequently, we studied the effect of opsonized E. coli
on the release of the MIP-2 in CLP-elicited macrophages.
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Fig. 1 Phagocytic activity of A2AWTand KO CLP-elicited peritoneal
macrophages. Peritoneal macrophages were harvested from A2A WT
and KO mice after 16 h of polymicrobial sepsis induced by cecal
ligation and puncture. Cells were seeded at 10
6/ml density in 96-well
plates. Peritoneal macrophages were then stimulated with IgG-coated,
FITC-labeled E. coli for 2.5, 5 or 16 h, and phagocytosis was
quantitated by measuring fluorescence. Results (mean ± SEM, n=5–8)
shown are one representative experiment from three separate studies
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Fig. 2 IL-10 release is decreased by peritoneal macrophages obtained
from A2A KO vs. WT mice. Peritoneal macrophages were obtained
from A2AWTand KO mice 16 h after cecal ligation and puncture. Cells
were plated at a density of 10
6/ml in 96-well plates. Cells were
stimulated with IgG-coated FITC-labeled E. coli for the indicated time
periods, and IL-10 release was measured using ELISA. Results (mean ±
SEM) depicted are from n=30–48 wells from six separate experiments.
*P<0.05, ***P<0.005 vs. A2A WT group
Purinergic Signalling (2007) 3:447–452 449As illustrated in Fig. 4, the MIP-2 release induced by
opsonized E. coli was higher in A2A KO (n=48) than WT
(n=30) macrophages.
Discussion
The most important result of this study is that the increased
bacterial clearance we found in septic A2A KO mice [32]i s
not due to the enhanced phagocytic activity of peritoneal
macrophages. Bacterial clearance is an elaborate process
that includes bacterial killing as well as phagocytosis by
macrophages and neutrophils. We reported in a previous
study that A2A receptor inactivation decreased bacterial
burden in septic mice [32]. Thus, in the present study we
questioned whether this decreased bacterial load in A2A KO
mice was due to enhanced phagocytosis by macrophages.
Our results indicated that this was not the case, because
A2A KO macrophages did not ingest greater numbers of
opsonized E. coli than WT macrophages.
The regulation of FcγR-mediated phagocytosis by
adenosine was one of the first effects described for this
purine nucleoside in modifying macrophage functionality
[35]. It is well known that adenosine augments FcγR-
mediated phagocytosis by human monocytes [30]. In
contrast to its stimulatory effect on phagocytosis by human
monocytes, adenosine reduced FcγR-mediated erythrocyte
phagocytosis by mouse peritoneal macrophages [36, 37],
suggesting that depending on the cellular stimulus and
source, adenosine may have differential effects on phago-
cytosis. In this study, we found that there was no difference
in the FcγR-mediated phagocytotic activity of A2A KO and
WT peritoneal macrophages. These results suggest that the
decreased bacterial burden in A2A KO mice under septic
conditions is not due to enhanced phagocytosis by macro-
phages. Since actual bacterial burden is determined by both
bacterial dissemination and clearance, and clearance is a
complex process that includes not only phagocytosis but
also killing of pathogens by macrophages and other cell
types, it will be important in the future to study how A2A
receptors govern all these bactericidal functions.
In a previous study [32], we showed that A2A receptor
inactivation decreased IL-10, IL-6, and MIP-2 production
in the bloodstream and in the peritoneum in CLP-induced
sepsis. In this study we observed that opsonized-E. coli-
induced IL-10 release was diminished in A2A KO perito-
neal macrophages in vitro. This finding is in accord with
our previous in vivo data obtained in the CLP model and
suggests that under septic conditions the decreased IL-10
level of A2A KO mice is due to a decreased production of
IL-10 by macrophages. In contrast to the in vivo results
showing decreased IL-6 and MIP-2 production in A2A
receptor-inactivated mice [32], we found that peritoneal
macrophages isolated from A2A KO mice showed enhanced
IL-6 and MIP-2 production as compared with WT macro-
phages. These results suggest that other cell types or other
macrophage populations may be responsible for IL-6 and
MIP-2 production under septic conditions. In this regard, it
is noteworthy that Riedemann et al. [38] demonstrated that
serum IL-6 concentrations during sepsis in rats are reduced
when neutrophils are depleted. Furthermore, it has been
reported that GdCl3 (a Kupffer cell-depleting agent)
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Fig. 4 Effect of genetic inactivation of the A2A receptor on MIP-2
production by CLP-elicited peritoneal macrophages. Peritoneal macro-
phages were obtained from A2A WT and KO mice 16 h after CLP.
Cells were plated at a density of 10
6/ml in 96-well plates. Cells were
stimulated with IgG-coated FITC-labeled E. coli for the indicated time
periods, and MIP-2 release was measured using ELISA. Results (mean
± SEM) depicted are from n=30–48 wells from six separate experi-
ments. ***P<0.05 vs. A2A WT group
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Fig. 3 Effect of genetic inactivation of the A2A receptor on IL-6
production by CLP-elicited peritoneal macrophages. Peritoneal macro-
phages were obtained from A2A WT and KO mice 16 h after cecal
ligation and puncture. Cells were plated at a density of 10
6/ml in 96-
well plates. Cells were stimulated with IgG-coated FITC-labeled E.
coli for the indicated time periods, and IL-6 release was measured
using ELISA. Results (mean ± SEM) depicted are from n=30–48
wells from six separate experiments. ***P<0.005 vs. A2A WT group
450 Purinergic Signalling (2007) 3:447–452prevents the up-regulation of IL-6 in a mouse septic
peritonitis model [39]. In addition, it has been shown that
MIP-2 production by liver mononuclear cells in mice with
peritonitis is significantly increased compared with sham-
operated mice, confirming the important role of Kupffer
cells in cytokine production during sepsis [40]. Therefore, it
is possible that either neutrophils or Kupffer cells, both of
which express A2A receptors [14, 25], are responsible for
the decreased IL-6 and MIP-2 levels that we detected in
A2A KO vs. WT mice [32].
In summary, A2A receptors differentially regulate im-
mune function in vitro and in vivo. In the future it will be
interesting to determine the mechanisms that are responsi-
ble for these differences.
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